Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 28

1.

mRNA Expression and Activity of Nucleoside Transporters in Human Hepatoma HepaRG Cells.

Mayati A, Moreau A, Jouan E, Febvre-James M, Denizot C, Parmentier Y, Fardel O.

Pharmaceutics. 2018 Nov 21;10(4). pii: E246. doi: 10.3390/pharmaceutics10040246.

2.

Functional polarization of human hepatoma HepaRG cells in response to forskolin.

Mayati A, Moreau A, Le Vée M, Bruyère A, Jouan E, Denizot C, Parmentier Y, Fardel O.

Sci Rep. 2018 Oct 31;8(1):16115. doi: 10.1038/s41598-018-34421-8.

3.

Evaluation of Drug Biliary Excretion Using Sandwich-Cultured Human Hepatocytes.

Fardel O, Moreau A, Le Vée M, Denizot C, Parmentier Y.

Eur J Drug Metab Pharmacokinet. 2019 Feb;44(1):13-30. doi: 10.1007/s13318-018-0502-x. Review.

PMID:
30167999
4.

Influence of PLA-PEG nanoparticles manufacturing process on intestinal transporter PepT1 targeting and oxytocin transport.

Gourdon B, Chemin C, Moreau A, Arnauld T, Delbos JM, Péan JM, Declèves X.

Eur J Pharm Biopharm. 2018 Aug;129:122-133. doi: 10.1016/j.ejpb.2018.05.022. Epub 2018 May 24.

PMID:
29803721
5.

New insights in the in vitro characterisation and molecular modelling of the P-glycoprotein inhibitory promiscuity.

Bocci G, Moreau A, Vayer P, Denizot C, Fardel O, Parmentier Y.

Eur J Pharm Sci. 2018 Aug 30;121:85-94. doi: 10.1016/j.ejps.2018.04.039. Epub 2018 Apr 28.

PMID:
29709579
6.

Functionalized PLA-PEG nanoparticles targeting intestinal transporter PepT1 for oral delivery of acyclovir.

Gourdon B, Chemin C, Moreau A, Arnauld T, Baumy P, Cisternino S, Péan JM, Declèves X.

Int J Pharm. 2017 Aug 30;529(1-2):357-370. doi: 10.1016/j.ijpharm.2017.07.024. Epub 2017 Jul 10.

PMID:
28705621
7.

β2-adrenergic receptor-mediated in vitro regulation of human hepatic drug transporter expression by epinephrine.

Mayati A, Moreau A, Denizot C, Stieger B, Parmentier Y, Fardel O.

Eur J Pharm Sci. 2017 Aug 30;106:302-312. doi: 10.1016/j.ejps.2017.06.010. Epub 2017 Jun 8.

PMID:
28603032
8.

Protein Kinases C-Mediated Regulations of Drug Transporter Activity, Localization and Expression.

Mayati A, Moreau A, Le Vée M, Stieger B, Denizot C, Parmentier Y, Fardel O.

Int J Mol Sci. 2017 Apr 4;18(4). pii: E764. doi: 10.3390/ijms18040764. Review.

9.

Effect of Gevokizumab on Interleukin-1β-Mediated Cytochrome P450 3A4 and Drug Transporter Repression in Cultured Human Hepatocytes.

Moreau A, Le Vée M, Jouan E, Denizot C, Parmentier Y, Fardel O.

Eur J Drug Metab Pharmacokinet. 2017 Oct;42(5):871-878. doi: 10.1007/s13318-017-0406-1.

PMID:
28260174
10.

Comparison of Screening Dilution and Automated Reading for Antinuclear Antibody Detection on HEP2 Cells in the Monitoring of Connective Tissue Diseases.

Depincé-Berger AE, Moreau A, Bossy V, Genin C, Rinaudo M, Paul S.

J Clin Lab Anal. 2016 Sep;30(5):471-8. doi: 10.1002/jcla.21881. Epub 2016 May 26.

PMID:
27225012
11.

Protein Kinase C-Independent Inhibition of Organic Cation Transporter 1 Activity by the Bisindolylmaleimide Ro 31-8220.

Mayati A, Bruyere A, Moreau A, Jouan E, Denizot C, Parmentier Y, Fardel O.

PLoS One. 2015 Dec 10;10(12):e0144667. doi: 10.1371/journal.pone.0144667. eCollection 2015.

12.

Protein kinase C-dependent regulation of human hepatic drug transporter expression.

Mayati A, Le Vee M, Moreau A, Jouan E, Bucher S, Stieger B, Denizot C, Parmentier Y, Fardel O.

Biochem Pharmacol. 2015 Dec 15;98(4):703-17. doi: 10.1016/j.bcp.2015.10.007. Epub 2015 Oct 14.

13.

Pharmacokinetics in IBD: ready for prime time?

Roblin X, Rinaudo M, Sparrow MP, Moreau A, Phelip JM, Genin C, Lamarque D, Paul S.

Curr Drug Targets. 2014;15(11):1049-55. Review.

PMID:
25173707
14.

Pharmacokinetics of adalimumab in inflammatory bowel diseases: a systematic review and meta-analysis.

Paul S, Moreau AC, Del Tedesco E, Rinaudo M, Phelip JM, Genin C, Peyrin-Biroulet L, Roblin X.

Inflamm Bowel Dis. 2014 Jul;20(7):1288-95. doi: 10.1097/MIB.0000000000000037. Review.

PMID:
24831559
15.

Association between 6-thioguanine nucleotides levels and clinical remission in inflammatory disease: a meta-analysis.

Moreau AC, Paul S, Del Tedesco E, Rinaudo-Gaujous M, Boukhadra N, Genin C, Peyrin-Biroulet L, Roblin X.

Inflamm Bowel Dis. 2014 Mar;20(3):464-71. doi: 10.1097/01.MIB.0000439068.71126.00.

PMID:
24418904
16.

Therapeutic drug monitoring of infliximab and mucosal healing in inflammatory bowel disease: a prospective study.

Paul S, Del Tedesco E, Marotte H, Rinaudo-Gaujous M, Moreau A, Phelip JM, Genin C, Peyrin-Biroulet L, Roblin X.

Inflamm Bowel Dis. 2013 Nov;19(12):2568-76. doi: 10.1097/MIB.0b013e3182a77b41.

PMID:
24013361
17.

Association between pharmacokinetics of adalimumab and mucosal healing in patients with inflammatory bowel diseases.

Roblin X, Marotte H, Rinaudo M, Del Tedesco E, Moreau A, Phelip JM, Genin C, Peyrin-Biroulet L, Paul S.

Clin Gastroenterol Hepatol. 2014 Jan;12(1):80-84.e2. doi: 10.1016/j.cgh.2013.07.010. Epub 2013 Jul 23.

PMID:
23891927
18.

Functional expression and regulation of drug transporters in monolayer- and sandwich-cultured mouse hepatocytes.

Noel G, Le Vee M, Moreau A, Stieger B, Parmentier Y, Fardel O.

Eur J Pharm Sci. 2013 Apr 11;49(1):39-50. doi: 10.1016/j.ejps.2013.01.013. Epub 2013 Feb 6.

19.

Drug transporter expression in human macrophages.

Moreau A, Le Vee M, Jouan E, Parmentier Y, Fardel O.

Fundam Clin Pharmacol. 2011 Dec;25(6):743-52. doi: 10.1111/j.1472-8206.2010.00913.x. Epub 2011 Jan 7.

PMID:
21210849
20.

Metabonomic studies on human hepatocyte in primary culture.

Croixmarie V, Umbdenstock T, Cloarec O, Moreau A, Pascussi JM, Parmentier Y, Boursier-Neyret C, Walther B.

Methods Mol Biol. 2010;640:355-74. doi: 10.1007/978-1-60761-688-7_19.

PMID:
20645062

Supplemental Content

Loading ...
Support Center